The landscape of structural variants in male infertility identified by optical genome mapping
Abstract
We aimed to determine what kind of structural genomic variants can be detected by optical genome mapping in patients with male infertility and whether such variants may contribute to male infertility. We performed a longitudinal case/control genetic study on patients with male infertility, negative for cytogenetic abnormalities using karyotyping, and molecular testing for chrY microdeletions, and CFTR gene variants, and compared them to healthy male individuals that underwent optical genomic mapping for other reasons. We tested a total of 220 individuals; 88 patients with male infertility and 132 control males. Exclusion criteria for the control cohort were low-sperm quality, known presence of cytogenetic rearrangements and/or inclusion in IVF procedures. We examined structural variants in 220 participants by using optical genome mapping, which was performed with DLE-1 SP-G2 chemistry and the Saphyr instrument. The de novo assembly and Variant Annotation Pipeline were executed on Bionano Solve3.7_20221013_25 while reporting and direct visualization of structural variants was done on Bionano Access 1.7.2. The male infertility cohort also underwent research whole exome analyses as previously reported. Results of optical genomic mapping were validated by multiple appropriate alternative methods where possible. We show that the overall number of structural variants in male infertility patients does not differ from that of healthy individuals. By looking in detail at genes and regions associated with MI, we identified 22 rare variants absent from controls in 25.0% of male infertility patients, of which five were likely causative, and two would be missed by using traditional approaches. These variants include inversions, duplications, amplifications, deletions (e.g. SPAG1 ), and insertions/expansions (e.g. DMPK ), that were validated using additional methods. Optical genome mapping can identify rare SV in male infertility patients that are absent from healthy controls. Most of the identified structural genomic variants cannot be currently classified as causative according to strict diagnostic criteria, and require a further functional characterization. Nevertheless, these findings open a new avenue in genetic research of SV involvement in MI.
Related
- 3D-genome impacts of TAD-boundary-disrupting ultra-rare structural variants identified in schizophrenia
- The role of methylation and structural variants in shaping the recombination landscape of barley
- The Genetic Landscape of Structural Variants in Aspergillus flavus using ONT and PacBio Sequencing
- Long-read sequencing reveals genomic landscape of structural variants in a major disease vector
- Genetic and Epigenetic Landscape of Self-Identified Hispanics/Latino in All Of Us
BibTeX
@article{kovanda2026landscape,
title = {{The landscape of structural variants in male infertility identified by optical genome mapping}},
author = {Anja Kovanda and Alenka Hodžić and Urška Kotnik and Tanja Višnjar and Rebeka Podgrajšek and Aleksander Andjelić and Helena Jaklič and Aleš Maver and Luca Lovrečić and Borut Peterlin},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-70834-6},
url = {https://www.nature.com/articles/s41598-026-70834-6},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The landscape of structural variants in male infertility identified by optical genome mapping
AU - Anja Kovanda
AU - Alenka Hodžić
AU - Urška Kotnik
AU - Tanja Višnjar
AU - Rebeka Podgrajšek
AU - Aleksander Andjelić
AU - Helena Jaklič
AU - Aleš Maver
AU - Luca Lovrečić
AU - Borut Peterlin
PY - 2026
DA - 2026/10/03
JO - Scientific Reports
DO - 10.1038/s41598-026-70834-6
UR - https://www.nature.com/articles/s41598-026-70834-6
AB - We aimed to determine what kind of structural genomic variants can be detected by optical genome mapping in patients with male infertility and whether such variants may contribute to male infertility. We performed a longitudinal case/control genetic study on patients with male infertility, negative for cytogenetic abnormalities using karyotyping, and molecular testing for chrY microdeletions, and CFTR gene variants, and compared them to healthy male individuals that underwent optical genomic mapping for other reasons. We tested a total of 220 individuals; 88 patients with male infertility and 132 control males. Exclusion criteria for the control cohort were low-sperm quality, known presence of cytogenetic rearrangements and/or inclusion in IVF procedures. We examined structural variants in 220 participants by using optical genome mapping, which was performed with DLE-1 SP-G2 chemistry and the Saphyr instrument. The de novo assembly and Variant Annotation Pipeline were executed on Bionano Solve3.7_20221013_25 while reporting and direct visualization of structural variants was done on Bionano Access 1.7.2. The male infertility cohort also underwent research whole exome analyses as previously reported. Results of optical genomic mapping were validated by multiple appropriate alternative methods where possible. We show that the overall number of structural variants in male infertility patients does not differ from that of healthy individuals. By looking in detail at genes and regions associated with MI, we identified 22 rare variants absent from controls in 25.0% of male infertility patients, of which five were likely causative, and two would be missed by using traditional approaches. These variants include inversions, duplications, amplifications, deletions (e.g. SPAG1 ), and insertions/expansions (e.g. DMPK ), that were validated using additional methods. Optical genome mapping can identify rare SV in male infertility patients that are absent from healthy controls. Most of the identified structural genomic variants cannot be currently classified as causative according to strict diagnostic criteria, and require a further functional characterization. Nevertheless, these findings open a new avenue in genetic research of SV involvement in MI.
SN - 2045-2322
ER -